Search Results - drug+resistant

2 Results Sort By:
Real-Time PCR Assay for HIV-1 Subtype Diagnosis and Global Surveillance of Drug Resistance
CDC researchers have developed a patented set of RT-PCR and sequencing primers based on HIV-1 group M sequences. Evaluation of the primers using samples collected around the world demonstrated broad detection capacity for multiple HIV-1 group subtypes and predominant circulating recombinant forms. Commercially available HIV-1 drug resistance (HIVDR)...
Published: 10/28/2024   |   Inventor(s): Joshua Devos, Nicholas Wagar, Zhiyong Zhou, Chunfu Yang
Keywords(s): AIDS, assay, blood-borne, CDC Docket Import, CDC Docket Import CDC Prosecuting, CGH-DGHA, DA4AXX, DA4XXX, DAXXXX, DEVELOPING, Diagnosis, diagnostic, DRUG, drug resistance, drug resistant, DXXXXX, EMERGING, EPIDEMIOLOGIC, Genotype, Genotyping, Global, HIV, HIV-1, Listed LPM Houze as of 4/15/2015, PCR, Post LPM Assignment Set 20150420, Pre LPM working set 20150418, Resistance, RESISTANT, RT-PCR, Surveillance, therapeutic, tropical, viral, virus
Category(s): Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Infectious Disease, Application > Diagnostics
Spindle Assembly Checkpoint Inhibition for Treatment of p53 Deficient Cancers
Reference #: 01405 The University of South Carolina is offering licensing opportunities for Re-sensitizing p53-null Stem Cells with Spindle Assembly Checkpoint Inhibition Background: TP53 is one of the most well-studied tumor suppressor genes and is known to be pivotal in response to DNA damage for cell cycle arrest, deterioration with age, or cell...
Published: 9/10/2024   |   Inventor(s): Phillip Buckhaults, Carolyn Banister, Changlong Liu
Keywords(s): Drug resistant, Resensitization, Spindle assembly checkpoint, TP53 null
Category(s): Chemistry and Biochemistry, Health Sciences, Biomedical and Life Sciences